UZLeuven, Gasthuisberg
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Verschueren, Patrick
RITUXERA, NCT06003283: Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis

Recruiting
4
134
Europe
Rituximab, MabThera, Truxima, Ruxience, Rixathon
Universitaire Ziekenhuizen KU Leuven, Fonds voor Wetenschappelijk Reumaonderzoek (FWRO)
Rheumatoid Arthritis
12/26
12/26
NCT06567470: A Study With CIT-013 in RA Patients

Not yet recruiting
2
150
Europe
CIT-013 low dose, CIT-013 high dose, Placebo
Citryll BV
Rheumatoid Arthritis
04/27
07/27
AEGORA, NCT05888181: App-based Education and GOal-setting in Rheumatoid Arthritis

Completed
N/A
126
Europe
Mobile app-based self-management intervention
Universitaire Ziekenhuizen KU Leuven, Sidekick Health
Rheumatoid Arthritis
02/24
02/24
Joly, Johan
RITUXERA, NCT06003283: Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis

Recruiting
4
134
Europe
Rituximab, MabThera, Truxima, Ruxience, Rixathon
Universitaire Ziekenhuizen KU Leuven, Fonds voor Wetenschappelijk Reumaonderzoek (FWRO)
Rheumatoid Arthritis
12/26
12/26
SPARTACUS, NCT04435288: Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade

Recruiting
3
112
Europe
week 24, week 36, Week 48, Week 60
University Hospital, Ghent, Merck Sharp & Dohme LLC
Peripheral Spondyloarthritis
05/25
05/26

Download Options